Astranova Research offers expert and customized health economics services to pharmaceutical and medical device companies. With the increasing demand for comprehensive evidence on the economic benefit, effectiveness, and health impact costs of products, our team provides tailored solutions to meet these requirements.
The rising levels of chronic illnesses globally, coupled with the increasing costs of treatment technologies, present significant challenges in managing the economic burden of these conditions. Programs aimed at preventing, treating, and managing chronic diseases and cancer can have profound economic implications for health sector budgets, individuals, and households. Regulators now expect feedback on these costs as a standard practice for approved products, making it imperative for companies to demonstrate economic benefit.
Our Health Economics team operates globally, with specialized expertise in the Asia-Pacific region.
Astranova Research's health economics services are led by experts with a wealth of experience in the field.
Astranova Research's health economics services team conduct innovative and high quality health economics research in the following areas:
The services we provide to our customers include:
